Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results - Wikidata - wikimedia - TriplyDB

Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results

Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results

http://www.wikidata.org/entity/Q35050383

about

Improving Brain Tumor Research in Resource-Limited Countries: A Review of the Literature Focusing on West Africa.Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.International Differences in Treatment and Clinical Outcomes for High Grade Glioma High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma.Physiological and pathophysiological roles for phospholipase D.miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells Understanding cytoskeleton regulators in glioblastoma multiforme for therapy design Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value.Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.Hugl-1 inhibits glioma cell growth in intracranial model.Carbon-ion beams effectively induce growth inhibition and apoptosis in human neural stem cells compared with glioblastoma A172 cells.Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss.A PTEN-COL17A1 fusion gene and its novel regulatory role in Collagen XVII expression and GBM malignance.Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.TERT Genetic Mutations as Prognostic Marker in Glioma.An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo

P2860

Q26775109-F714736C-B633-4159-AB4E-FFF63FEE944C Q28546959-FAF5FCA2-889C-4457-8017-FB2B54168EC4 Q33686433-43C9C88E-4236-4925-8E2D-41BB4DDE8B2F Q35659472-A323503D-6150-493D-8BCF-694F1F69CB08 Q36150889-13539D22-1B75-431A-A977-A704268FF7A1 Q36307313-A90DAE4E-E62C-4242-BC69-2036B5B24D8B Q36782656-F9B3DC0F-B155-4889-B214-8D588D967306 Q37261902-91CCE557-79E9-4B1E-8F66-2271A778DD76 Q37606664-D03822FE-3B64-4563-8676-E8CE8870E62C Q37688554-79140799-FE3F-4868-80DF-4D16654A240E Q38401359-55F47F9F-326C-4B89-9226-8D3CBC25A767 Q38468970-97DC7C0A-6F24-4075-82B4-F8E809D37804 Q38665185-598D382C-3266-4160-8C0F-2901823FBF0A Q38742113-0A3503C7-840D-4228-AAD7-F3AFDC1B67A4 Q38837760-F03F8580-0632-47D0-93D7-3230AECA7E46 Q38864604-5CE8CBA3-E177-46A7-896D-895D12BA34BC Q42376082-1A9D0320-B41C-4DA5-B774-9941637A35AE Q45718757-6296330E-AE61-4682-9BE9-E4CCB18AC276 Q48003634-BE1C56BE-4CE0-4BD5-8F6D-6CE17D14DF1C Q55022358-FE433C55-E6D0-4287-B1C2-29D80320A2CD Q57493904-B0294E02-58DB-4FB7-8EB5-845BA4C9670E

P2860

Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results

http://www.wikidata.org/entity/Q35050383

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Radiotherapy plus concomitant ...... ese mono-institutional results

@ast

Radiotherapy plus concomitant ...... ese mono-institutional results

@en

type

label

Radiotherapy plus concomitant ...... ese mono-institutional results

@ast

Radiotherapy plus concomitant ...... ese mono-institutional results

@en

prefLabel

Radiotherapy plus concomitant ...... ese mono-institutional results

@ast

Radiotherapy plus concomitant ...... ese mono-institutional results

@en

P1433

Q35050383-6C9BEF2B-3D63-4752-A745-D0D24C92B29D

P1476

Q35050383-917503E9-93E0-4B10-B2C2-68537DC85936

P2093

Q35050383-08086C47-5C5C-4B41-BC43-29041D2DA937

Q35050383-12DD7586-46C3-4FEF-B9CB-6903689C2675

Q35050383-1DAEFF63-B81C-4663-8932-201E44A03C07

Q35050383-23F2B240-6BC9-4886-881E-83D914E78F45

Q35050383-5B75B6A4-A9F9-41B2-9603-A7F861EB5622

Q35050383-86E9674D-DC1C-4112-B195-19E8BCE7DE9C

Q35050383-97FE44A9-F07B-4550-802C-3C1C427B83A5

Q35050383-B6AC1DA4-AF7B-4A73-94FA-0451E0DCA491

Q35050383-C512AC55-4378-4493-9590-8680736A8363

Q35050383-F0ED72BA-5021-4FB7-915B-62C1135B7292

P2860

Q35050383-0EA957B0-1720-4A72-B130-8BFD661ED951

Q35050383-12C48D36-AFD6-458F-B8B6-0A4805ADBBE4

Q35050383-18F9E4D3-0EF8-4B9C-8FB5-3F5247194EEA

Q35050383-2369F928-40CC-46BB-AA76-5B1D5D86527F

Q35050383-23FCDAD4-233C-4015-A604-61CC43FFA913

Q35050383-37C99084-2814-4FBD-B827-8C5E217B368F

Q35050383-3E716A89-0234-47DD-B1D1-8563B975FC17

Q35050383-6C497197-8F83-4174-865A-535FEFBE8970

Q35050383-73063D5A-605A-482E-9D0E-64E35389C619

Q35050383-7B09BEFB-A754-4F90-BAD4-D29D78F23DE3

P304

Q35050383-A85CC76B-E02F-4575-86BF-08194441101C

P31

Q35050383-5B75590F-1769-4F32-9AAE-9B2F8BE499AD

P356

Q35050383-654E57FD-5007-42FC-9FD9-D0B551001166

P407

Q35050383-9C90D067-D630-4D44-95F3-A851786D2DED

P433

Q35050383-582BB56F-3BB4-4138-AB83-FE7B54EC1BE7

P478

Q35050383-732560CD-B4D1-4831-9FE8-955013FCD5E9

P577

Q35050383-28D6A059-A8C3-434B-96E2-DE7842611E18

P5875

Q35050383-9E1C6FCE-3F67-41B9-A2D1-E927A7FFDF38

P698

Q35050383-ECF345F9-41E5-455F-BD5B-DE9D4170DBFE

P921

Q35050383-D720F8E1-8F1A-4A39-9403-C339DE6644C0

P932

Q35050383-321774CA-179C-487D-9BF6-CC4E01D1303B

P356

JOURNAL.PONE.0078943

P1433

P1476

Radiotherapy plus concomitant ...... ese mono-institutional results

@en

P2093

Hideaki Yokoo

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Shirai

http://www.w3.org/2001/XMLSchema#string

Ken-ichi Sugawara

http://www.w3.org/2001/XMLSchema#string

Masaya Nagaishi

http://www.w3.org/2001/XMLSchema#string

Shin-ei Noda

http://www.w3.org/2001/XMLSchema#string

Takahiro Oike

http://www.w3.org/2001/XMLSchema#string

Takashi Nakano

http://www.w3.org/2001/XMLSchema#string

Tomoaki Tamaki

http://www.w3.org/2001/XMLSchema#string

Yoichi Nakazato

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

MGMT: its role in cancer aetiology and cancer therapeutics.

Ki67 protein: the immaculate deception?

P304

e78943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0078943

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258830979

http://www.w3.org/2001/XMLSchema#string

P698

24265731

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3827088

http://www.w3.org/2001/XMLSchema#string